Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia is a research paper published in Schizophrenia Research (2023). On theSindex it has a DataRank of 0.473. It has been cited 9 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.128
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
NCATS NIH HHS
Grant: UH2 TR000960
NCRR NIH HHS
Grant: UL1 RR024139
U.S. Department of Veterans Affairs
Grant: UL1 TR001863
National Institute on Alcohol Abuse and Alcoholism
Grant: P50AA012870
National Center for Advancing Translational Sciences
Grant: 1UH2TR000960-01
Pfizer Pharmaceuticals
Grant: PF-03463275
NCATS NIH HHS
Grant: UH3 TR000960
National Institutes of Health
Ohio Department of Mental Health and Addiction Services
FWCI
1.59
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords